The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Primary Hyperoxaluria
Abstract
The primary hyperoxalurias are a group of autosomal recessive disorders of endogenous oxalate overproduction. This review discusses the major biochemical, genetic, and therapeutic advances that have led to a better understanding of the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1β secretion
Mulay, S. R., Kulkarni, O. P., Rupanagudi, K. V., Migliorini, A., Darisipudi, M. N., Vilaysane, A., Muruve, D., Shi, Y., Munro, F., Liapis, H., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci63679 · Cited by 468
Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment
Cochat, P., Hulton, S.-A., Acquaviva, C., Danpure, C. J., Daudon, M., De Marchi, M., Fargue, S., Groothoff, J., Harambat, J., Hoppe, B., et al. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs078 · Cited by 335
Self-citationAn update on primary hyperoxaluria
Hoppe, B. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.113 · Cited by 312
Mutations in DHDPSL Are Responsible For Primary Hyperoxaluria Type III
Belostotsky, R., Seboun, E., Idelson, G. H., Milliner, D. S., Becker-Cohen, R., Rinat, C., Monico, C. G., Feinstein, S., Ben-Shalom, E., Magen, D., et al. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.07.023 · Cited by 233
Epidemiology of primary hyperoxaluria type 1
Cochat, P., Deloraine, A., Rotily, M., Olive, F., Liponski, I., Deries, N., & Pediatrique, O. B. O. T. S. D. N. A. T. S. D. N. (1995) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/10.supp8.3 · Cited by 186
Self-citationTransplantation Outcomes in Primary Hyperoxaluria
Bergstralh, E. J., Monico, C. G., Lieske, J. C., Herges, R. M., Langman, C. B., Hoppe, B., & Milliner, D. S. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03271.x · Cited by 182
Primary hyperoxaluria type 1 in The Netherlands: prevalence and outcome
van Woerden, C. S. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/18.2.273 · Cited by 180
Primary hyperoxaluria type 1: update and additional mutation analysis of the AGXT gene
Williams, E. L., Acquaviva, C., Amoroso, A., Chevalier, F., Coulter-Mackie, M., Monico, C. G., Giachino, D., Owen, T., Robbiano, A., Salido, E., et al. (2009) · Human Mutation · doi:10.1002/humu.21021 · Cited by 175
Self-citationHarambat, J., Fargue, S., Acquaviva, C., Gagnadoux, M.-F., Janssen, F., Liutkus, A., Mourani, C., Macher, M.-A., Abramowicz, D., Legendre, C., et al. (2010) · Kidney International · doi:10.1038/ki.2009.435 · Cited by 158
Self-citationCharacteristics and Outcomes of Children with Primary Oxalosis Requiring Renal Replacement Therapy
Harambat, J., van Stralen, K. J., Espinosa, L., Groothoff, J. W., Hulton, S., Čerkauskienė, R., Schaefer, F. S., Verrina, E. E., Jager, K. J., & Cochat, P. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07430711 · Cited by 154
Self-citationInternational Registry for Primary Hyperoxaluria
Lieske, J. C., Monico, C. G., Holmes, W. S., Bergstralh, E. J., Slezak, J. M., Rohlinger, A. L., Olson, J. B., & Milliner, D. S. (2005) · American Journal of Nephrology · doi:10.1159/000086360 · Cited by 150
Hatch, M., Gjymishka, A., SALIDO, E. C., Allison, M. J., & Freel, R. W. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00434.2010 · Cited by 147
Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria
Höppe, B., Groothoff, J. W., Hulton, S., Cochat, P., Niaudet, P., Kemper, M. J., Deschênes, G., Unwin, R. J., & Milliner, D. S. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr107 · Cited by 146
Self-citationSantana, A., SALIDO, E. C., Torres, A., & Shapiro, L. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1131968100 · Cited by 125
SALIDO, E. C., Li, X. M., Lu, Y., Wang, X., Santana, A., Roy‐Chowdhury, N., Torres, A., Shapiro, L. J., & Roy‐Chowdhury, J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607218103 · Cited by 125
Multiple mechanisms of action of pyridoxine in primary hyperoxaluria type 1
Fargue, S., Rumsby, G., & Danpure, C. J. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.04.010 · Cited by 114
Self-citationGlycolate and glyoxylate metabolism in HepG2 cells
Baker, P. R. S., Cramer, S. D., Kennedy, M., Assimos, D. G., & Holmes, R. P. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00238.2004 · Cited by 110
The Primary Hyperoxalurias: An Algorithm for Diagnosis
Milliner, D. S. (2005) · American Journal of Nephrology · doi:10.1159/000085407 · Cited by 106
Fargue, S., Lewin, J. F., Rumsby, G., & Danpure, C. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.432617 · Cited by 89
Self-citationPrimary hyperoxaluria type III—a model for studying perturbations in glyoxylate metabolism
Belostotsky, R., Pitt, J. J., & Frishberg, Y. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0930-z · Cited by 81
Cardiac Abnormalities in Primary Hyperoxaluria
Mookadam, F., Smith, T., Jiamsripong, P., Moustafa, S., Monico, C. G., Lieske, J. C., & Milliner, D. S. (2010) · Circulation Journal · doi:10.1253/circj.cj-10-0107 · Cited by 81
Beck, B. B., Baasner, A., Buescher, A. K., Habbig, S., Reintjes, N., Kemper, M. J., Sikora, P., Mache, C. J., Pöhl, M., Stahl, M., et al. (2012) · European Journal of Human Genetics · doi:10.1038/ejhg.2012.139 · Cited by 79
End-stage renal disease of the Tunisian child: epidemiology, etiologies, and outcome
Kamoun, A., & Lakhoua, R. (1996) · Pediatric Nephrology · doi:10.1007/s004670050143 · Cited by 70
Behnam, J. T., Williams, E. L., Brink, S. C., Rumsby, G., & Danpure, C. J. (2006) · Biochemical Journal · doi:10.1042/bj20051397 · Cited by 68
Self-citationEffect of conservative treatment on the renal outcome of children with primary hyperoxaluria type 1
Fargue, S., Harambat, J., Gagnadoux, M., Tsimaratos, M., Janssen, F., Llanas, B., Berthélémé, J.-P., Boudailliez, B. R., Champion, G., Guyot, C., et al. (2009) · Kidney International · doi:10.1038/ki.2009.237 · Cited by 68
Self-citationSikora, P., Unruh, G. E. V., Beck, B. B., Feldkötter, M., Zajączkowska, M., Hesse, A., & Höppe, B. (2008) · Kidney International · doi:10.1038/ki.2008.63 · Cited by 57
de Lorenzo, V., Alvarez, A., Torres, A., Torregrosa, V., Hernández, D., & SALIDO, E. C. (2006) · Kidney International · doi:10.1038/sj.ki.5001758 · Cited by 56
Jiang, J., SALIDO, E. C., Guha, C., Wang, X., Moitra, R., Liu, L., Roy‐Chowdhury, J., & Roy‐Chowdhury, N. (2008) · Transplantation · doi:10.1097/tp.0b013e31816de49e · Cited by 52
Beck, B. B., Habbig, S., Dittrich, K., Stippel, D. L., Kaul, I., Koerber, F., Goebel, H., SALIDO, E. C., Kemper, M. J., Meyburg, J., et al. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr776 · Cited by 52
Feasibility of Hepatocyte Transplantation-Based Therapies for Primary Hyperoxalurias
Guha, C., Yamanouchi, K., Jiang, J., Wang, X., Chowdhury, N. R., Santana, A., Shapiro, L. J., SALIDO, E. C., & Roy‐Chowdhury, J. (2005) · American Journal of Nephrology · doi:10.1159/000085408 · Cited by 48
Hydroxyproline metabolism in mouse models of primary hyperoxaluria
Knight, J. L., Holmes, R. P., Cramer, S. D., Takayama, T., & SALIDO, E. C. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00473.2011 · Cited by 42
Dietzen, D. J., Wilhite, T. R., Kenagy, D. N., Milliner, D. S., Smith, C. H., & Landt, M. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.8.1315 · Cited by 25
Cited by
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
Garrelfs, S. F., Frishberg, Y., Hulton, S. A., Koren, M. J., O’Riordan, W. D., Cochat, P., Deschênes, G., Shasha-Lavsky, H., Saland, J. M., van’t Hoff, W. G., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021712 · Cited by 531
Self-citationBiochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update
Vanholder, R., Pletinck, A., Schepers, E., & Glorieux, G. (2018) · Toxins · doi:10.3390/toxins10010033 · Cited by 356
Scott, L. J., & Keam, S. J. (2021) · Drugs · doi:10.1007/s40265-020-01463-0 · Cited by 292
RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies
Traber, G. M., & Yu, A.-M. (2023) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.122.001234 · Cited by 291
Phenotype-Genotype Correlations and Estimated Carrier Frequencies of Primary Hyperoxaluria
Hopp, K., Cogal, A. G., Bergstralh, E. J., Seide, B. M., Olson, J. B., Meek, A. M., Lieske, J. C., Milliner, D. S., & Harris, P. C. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014070698 · Cited by 267
Metadata
- Authors
- Cochat, P., & Rumsby, G.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2013-08-15
- Volume
- 369
- Issue
- 7
- Pages
- 649-658
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4236938577
- Cited by
- 586
- References
- 32
- FWCI
- 22.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.